VC-backed C4 Therapeutics goes public

C4 Therapeutics, a biopharmaceutical company, has raised $182.4 million for its IPO after pricing its 9.6 million shares at $19 per share.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this